Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

LifeSpex Inc.

Latest From LifeSpex Inc.

Optical Detection: From Physicists to Physicians

Several companies formed in the 1990's are poised to validate the clinical potential of light-based diagnostics as they guide through clinical trials products for a wide variety of applications in cancer, dermatology, gastrointestinal and cardiovascular diseases. Developers of the new optical imaging technologies ultimately hope to improve the way physicians diagnose diseases, by enabling insight into conditions where detection is currently inadequate. They hope to improve outcomes by detecting diseases at earlier stages, before pathological changes become visible. Finally, they aim to develop non-invasive systems that offer rapid diagnosis at the point of care, so that physicians can see and treat patients in a single visit. For now, though, companies are approaching the market cautiously. Most have a strategy of getting their products approved for adjunctive applications rather than attempting to win approval for the devices as standalone diagnostic systems that replace current screening methods.

Medical Device Platform Technologies

Cyrano Sciences Inc.

Cyrano Sciences' electronic olfaction technology simulates the nose's ability to sense chemicals present in vapors. The technology has a variety of industrial and medical applications such as point of care diagnostics. The company's "nose chips"--microarrays of sensors, could be built into diagnostic devices that can non-invasively detect conditions like bacterial infections of the ear.

Medical Device Platform Technologies

LifeSpex Inc.

Diagnostics. LifeSpex is taking a different approach to the problem of cervical cancer detection. It is examining living tissue, using a non-invasive, point-of-care system that yields information about the source and location of abnormal tissue. {Cerviscan} uses {in vivo} fluorescence spectroscopy to measure the differences in the way abnormal and normal tissues absorb and emit light.

Medical Device Platform Technologies
See All

Company Information

  • Industry
  • Medical Devices
    • Diagnostic Equipment & Supplies
UsernamePublicRestriction

Register